This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress

Saving Ends In...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025Thomas Michael Menino Convention & Exhibition Center, Boston, USA
Tickets
Menu
Tickets

Pierandrea Muglia
CMO at Saniona
Speaker

Profile

Pierandrea Muglia, M.D., is Chief Medical Officer at Saniona, a Danish biotech listed on Nasdaq Stockholm (SANION). He previously served as President and Founder of GRIN Therapeutics, CMO at Handl Therapeutics, VP of Neurology Early Clinical Development at UCB, VP of Clinical Development at NeuroSearch, and Director of Translational Medicine at GSK. Clinically trained in neuropsychiatry, Dr. Muglia has over 30 years of experience in neuroscience R&D and has led the development of numerous drug candidates across neurological and psychiatric indications in both pharma and biotech settings.

Agenda Sessions

  • A Centrally Acting Approach for Obesity with Oral Triple Monoamine Reuptake Inhibitor

    , 2:55pm
    View Session

At this event

Prev
Next
Jukka Muhonen
VP Business Development
Orphagen Pharmaceuticals

See Pierandrea at LSX USA Congress

Tickets